longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

MRNA

MRNA
135.6103.36%( -4.720 )

LongbridgeAI

Moderna Chief Legal Officer Shannon Thyme Klinger disposes of USD 485,271.45 in common shares

PUBT
Sep 3, 2026 at 08:57 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Moderna Chief Legal Officer Shannon Thyme Klinger sold 4,519 common shares on September 1, 2026, totaling approximately USD 485,271. The transaction included selling 3,471 shares at USD 139.95 and withholding 1,048 shares for taxes. Following the sale and exercise of options, her holdings decreased to 75,247 shares.

  • Moderna Chief Legal Officer Klinger Shannon Thyme reported net sales of 4,519 common shares on Sep. 1, 2026. * Sale price USD 139.95 for 3,471 shares; 1,048 shares withheld for taxes at USD 140.34. * Holdings fell to 75,247 shares following the transactions. * Also exercised options for 3,471 shares at USD 30.96; 2,166 restricted stock units converted into common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moderna Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001682852-26-000167), on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Login to unlock606characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Moderna

Moderna

USMRNA

-3.36%

MRNA 2X Long ETF

MRNA 2X Long ETF

USMRNX

YieldMax MRNA Option Income Strategy ETF

YieldMax MRNA Option Income Strategy ETF

USMRNY